Why the study?
Does ibopamine improve ventricular remodeling and preserve cardiac function in rats with experimental myocardial infarction?
Does ibopamine improve ventricular remodeling and preserve cardiac function in rats with experimental myocardial infarction?
Ibopamine, an orally active dopamine agonist, attenuates ventricular remodeling and preserves cardiac function after experimental MI in rats, comparable to the effects of captopril.
No takes yet. Share an insight, caveat, or question.
Should not yet inform clinical use of ibopamine post-MI; leaves open translation of remodeling benefits to human trials.
Gilst et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: